Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trial

Circulation

Volumn 123, Issue 22, 2011, Pages 2571-2578

  Blackshear, Joseph L ^a   Cutlip, Donald E ^b   Roubin, Gary S ^c   Hill, Michael D ^d   Leimgruber, Pierre P ^e   Begg, Richard J ^f   Cohen, David J ^g   Eidt, John F ^h   Narins, Craig R ⁱ   Prineas, Ronald J ^j   Glasser, Stephen P ^k   Voeks, Jenifer H ^k   Brott, Thomas G ^a  

^a MAYO CLINIC   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c LENOX HILL HOSPITAL   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e Heart Institute of Spokane   (United States)

^f Heritage Valley Health System   (United States)

^g Saint Luke's Mid America Heart and Vascular Institute   (United States)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

carotid arteries; endarterectomy, carotid; myocardial infarction; prognosis; stents; troponin

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; TROPONIN I; TROPONIN T;

AGED; ARTICLE; CAROTID ARTERY STENTING; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ECG ABNORMALITY; ELECTROCARDIOGRAM; ENDARTERECTOMY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; THORAX PAIN;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERIES; CEREBRAL REVASCULARIZATION; ELECTROCARDIOGRAPHY; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 79958864709     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.008250     Document Type: Article

References (36)

1. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
2. Davis SM, Donnan GA. Carotid-artery stenting in stroke prevention. N Engl J Med. 2010;363:800-882.
3. Kim LJ, Martinez EA, Faraday N, Dorman T, Fleisher LA, Perler BA, Williams GM, Chan D, Pronovost PJ. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circ. 2002;106: 2366-2371. (Pubitemid 35244739)
4. Landesberg G, Shatz V, Akopnik I, Wolf YG, Mayer M, Berlatzky Y, Weissman C, Mosseri M. Association of cardiac troponin, CK-MB, and postoperative survival after major vascular surgery. J Am Coll Cardiol. 2003;42:1547-1554. (Pubitemid 37378430)
5. Oscarsson A, Eintrei C, Anskar S, Engdahl O, Fagerstrom L, Blomquist P, Fredriksson M, Swahn E. Troponin T-values provide long-term prognosis in elderly patients undergoing non-cardiac surgery. Acta Anaesth Scand. 2004;48:1071-1079. (Pubitemid 39274122)
6. Bursi F, Babuin L, Barbieri A, Politi L, Zennaro M, Grimaldi T, Rumolo A, Gargiulo M, Stella A, Modena MG, Jaffe AS. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines: the additive roles of post-operative troponin elevation. Eur Heart J. 2005;26:2448-2456. (Pubitemid 41552975)
7. McFalls EO, Ward HB, Mortiz TE, Apple FS, Goldman S, Pierpont G, Larsen GC, Hattler B, Shunk K, Littooy F, Santilli S, Rapp J, Thottapurathu L, Krupski W, Reda DJ, Handerson WG. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with a documented coronary artery disease: results of the CARP trial. Eur Heart J. 2008;29:394-401. (Pubitemid 351197766)
8. DeHert SG, Longrois D, Yang H, Fleisher LA. Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta Anaesth Belg. 2008;59:19-25. (Pubitemid 351500616)
9. Chong CP, Lam QT, Ryan JE, Sinnappu RN, Lim WK. Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. Age Ageing. 2009;38:168-174.
10. Cavallini C, Rugolotto M, Savonitto S. Prognostic significance of creatine kinase release after percutaneous coronary intervention. Ital Heart J. 2005;6:522-529.
11. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR Jr, Rihal CS. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006; 48:1765-1770. (Pubitemid 44648624)
12. Lopez-Jimenez F, Goldman L, Sacks DB, Thomas EJ, Johnson PA, Cook EF, Lee TH. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll Cardiol. 1997;29:1241-1245. (Pubitemid 27201941)
13. Le Manch Y, Perel A, Coriat P, Godet G, Bertrand M, Riou B. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology. 2005;102:885-891. (Pubitemid 40590068)
14. Kertai MD, Boersma E, Klein J, van Urk H, Baxt JJ, Poldermans D. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur J Vasc Endovasc Surg. 2004;28:59-66. (Pubitemid 38950140)
15. Nienhuis MB, Ottervanger JP, Bilo HJG, Dikkeshchei BD, Zijlstra F. Prognostic value of troponin after elective percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2008;71: 318-324. (Pubitemid 351428148)
16. Hopkins LN, Roubin GS, Chakhtoura EY, Gray WA, Ferguson RD, Katzen BT, Rosenfield K, Goldstein J, Cutlip DE, Morrish W, Lal BK, Sheffet AJ, Tom M, Hughes S, Voeks J, Kathir K, Meschia JF, Hobson RW 2nd, Brott TG. The Carotid Revascularization Endarterectomy Vs Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis. 2010;19:153-162.
17. Sheffet AJ, Roubin G, Howard G, Howard V, Moore W, Meschia J, Hobson RW 2nd, Brott TG. Design of the carotid revascularization endarterectomy vs. Stenting trial (CREST). Int J Stroke. 2010;5: 40-46.
18. Hobson RW 2nd. CREST (Carotid Revascularization Endarterectomy Versus Stent Trial): background, design, and current status. Semin Vasc Surg. 2000;13:139-143. (Pubitemid 30397174)
19. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001; 141:190-199.
20. Goodman SG, Steg PG, Eagle KA, Foss KAA, Lopez-Sendon J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfunkel EP. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006;151:654-660. (Pubitemid 43290256)
21. Malasky BR, Alpert JS. Diagnosis of myocardial injury by biochemical markers: problems and promises. Cardiol Rev. 2002;10:306-317.
22. Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol. 2008;51:307-314.
23. Tzivoni D, Koukoui D, Guetta V, Novack L, Cowing G; CASTEMI Study Investigators. Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2008;101:753-757.
24. Hallen J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009;104: 1472-1477.
25. Licka M, Zimmerman R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart. 2002;87:520-524. (Pubitemid 34547973)
26. Bohmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S. Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months. Cardiology. 2009; 113:207-212.
27. Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol. 2006; 48:2192-2194. (Pubitemid 44855412)
28. Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart. 2007;93: 1547-1551. (Pubitemid 350205547)
29. Hassan AKM, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, Atsma DE, Schalij MJ, Jukema JW. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol. 2009;103:779-784.
30. Meier P, Knapp G, Tamhane U, Chaturvedi S, Gurm HS. Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomized controlled clinical trials. BMJ. 2010;340:c467.
31. Knur R. Carotid artery stenting: a systematic review of randomized clinical trials. Vasa. 2009;38:281-291.
32. Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, Lo TH, Gaines P, Dorman PJ, Macdonald S, Lyrer PA, Hendriks JM, McCollum C, Nederkoorn PJ, Brown MM; International Carotid Stenting Study Investigators. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomized controlled trial. Lancet. 2010:375:985-997.
33. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K. Protected carotid-artery stenting versus endarterectomy in high risk patients. N Engl J Med. 2004;351: 1493-1501.
34. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio D, on behalf of the ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Study. Circulation. 2004;110:674-678. (Pubitemid 39056265)
35. Motamed C, Motamed-Kazerounian G, Merle JC, Dumerat M, Yakhou L, Vodinh J, Kouyoumoudjian C, Duvaldestin P, Bedquemin JP. Cardiac troponin I assessment and late cardiac complications after carotid stenting or endarterectomy. J Vasc Surg. 2005;41:769-774. (Pubitemid 40693796)
36. Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Enogoren M, Alexander JH, Leby JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011;305:585-591.